The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / L•• H•••••••••

5CP News 5•• C•••••• P••••••• Announces Investment in L•• H••••••••• The transaction represents 5•• C•••••• P•••••••’ sixth investment from Fund I and further expands the firm’s role in healthcare.

Majority investmentclosedannounced Dec 15, 2022closed Dec 15, 2022Fact
What happened
Target
L•• H•••••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / healthcare, hospital, medical
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
6 named
Buy side
  • M•••••• T••••••Deal partnerconfirmed
    ““LSL plays an integral role in the healthcare ecosystem because they create products that are essential for the delivery of care,” said M•••••• T••••••, managing partner at 5•• C•••••• P•••••••.”
  • 5•• C•••••• P•••••••Sponsorconfirmed
    “5•• C•••••• P•••••••, a purpose-driven private investment firm committed to driving economic and social impact, today announced that it has made a majority investment in L•• H••••••••• (“LSL”), a leading manufacturer of single-use medical devices, IV start kits, surgical procedure kits and hospital ”
Financing side
Advisory side
  • D•• P••••Legal adviserconfirmed
    “D•• P•••• served as legal counsel to 5•• C•••••• P•••••••, and K•••• A••••••• C•••••• A••••••• provided debt financing to support the transaction.”
Side not stated
  • A•• L•••••Managementconfirmed
    ““This is an exciting next step in LSL’s growth journey. 5 th C•••••• Partners has already been an incredible partner throughout this process, and we expect to greatly benefit from their deep experience in the healthcare space,” said A•• L•••••, founder and CEO at L•• H•••••••••.”
  • L•• H•••••••••Targetconfirmed
    “5•• C•••••• P•••••••, a purpose-driven private investment firm committed to driving economic and social impact, today announced that it has made a majority investment in L•• H••••••••• (“LSL”), a leading manufacturer of single-use medical devices, IV start kits, surgical procedure kits and hospital ”
Evidence
“5•• C•••••• P•••••••, a purpose-driven private investment firm committed to driving economic and social impact, today announced that it has made a majority investment in L•• H••••••••• (“LSL”), a leading manufacturer of single-use medical devices, IV start kits, surgical procedure kits and hospital supplies.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 18, 2026
5CP News 5•• C•••••• P••••••• Announces Investment in L•• H••••••••• The transaction repre | Private Equity Intelligence | DFX